Sangamo Therapeutics Inc (NASDAQ: SGMO) – Analysts’ Revisions Show Sentiment Is Improving
Sangamo Therapeutics Inc (NASDAQ:SGMO) traded at $0.99 at close of the session on Tuesday, March 11 and made an upward move of 0.33% on its previous day’s price. Sangamo Therapeutics Inc has a market cap of $206.96 million and is expected to release its quarterly